0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S77
DOI: 10.1016/j.jid.2026.06.478 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von D. Wambold und 4 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wambold, D., Alani, O., Shqair, L., Rahman, S., & Haque, A. (2026). 0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study. Journal of Investigative Dermatology, 146(8), S77. https://doi.org/10.1016/j.jid.2026.06.478
Vancouver
Wambold D, Alani O, Shqair L, Rahman S, Haque A. 0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study. Journal of Investigative Dermatology. 2026;146(8):S77. doi:10.1016/j.jid.2026.06.478
BibTeX
@article{Wambold2026,
author = {Wambold, D. and Alani, O. and Shqair, L. and Rahman, S. and Haque, A.},
title = {0447 Cutaneous outcomes following glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: A propensity-matched trinetx cohort study},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S77},
doi = {10.1016/j.jid.2026.06.478}
}
EUVIMED